{"abstract": "Pfizer, one of the three companies behind the drug, said it did not improve either cognition or daily functioning compared to a placebo.", "web_url": "https://www.nytimes.com/2012/07/24/business/alzheimers-drug-fails-its-first-clinical-trial.html", "snippet": "Pfizer, one of the three companies behind the drug, said it did not improve either cognition or daily functioning compared to a placebo.", "lead_paragraph": "The most closely watched experimental treatment for Alzheimer\u2019s disease proved ineffective in its first large clinical trial, dealing a blow to the field, to a theory about the cause of the disease, and to the three companies behind the drug.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "Alzheimer\u2019s Drug Fails Its First Big Clinical Trial", "kicker": null, "content_kicker": null, "print_headline": "Alzheimer\u2019s Drug Fails First Big Clinical Trial", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Clinical Trials", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Alzheimer's Disease", "rank": 4, "major": "N"}], "pub_date": "2012-07-24T01:23:30+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/3c443f8b-3d6a-5b4a-8583-c537807f92cc", "word_count": 640, "uri": "nyt://article/3c443f8b-3d6a-5b4a-8583-c537807f92cc"}